Cargando…

Late‐Stage (18)F‐Difluoromethyl Labeling of N‐Heteroaromatics with High Molar Activity for PET Imaging

Despite a growing interest in CHF(2) in medicinal chemistry, there is a lack of efficient methods for the insertion of CHF(18)F into druglike compounds. Herein described is a photoredox flow reaction for (18)F‐difluoromethylation of N‐heteroaromatics that are widely used in medicinal chemistry. Foll...

Descripción completa

Detalles Bibliográficos
Autores principales: Trump, Laura, Lemos, Agostinho, Lallemand, Bénédicte, Pasau, Patrick, Mercier, Joël, Lemaire, Christian, Luxen, André, Genicot, Christophe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6790700/
https://www.ncbi.nlm.nih.gov/pubmed/31323171
http://dx.doi.org/10.1002/anie.201907488
Descripción
Sumario:Despite a growing interest in CHF(2) in medicinal chemistry, there is a lack of efficient methods for the insertion of CHF(18)F into druglike compounds. Herein described is a photoredox flow reaction for (18)F‐difluoromethylation of N‐heteroaromatics that are widely used in medicinal chemistry. Following the two‐step synthesis for a new (18)F‐difluoromethylation reagent, the photoredox reaction is completed within two minutes and proceeds by C−H activation, circumventing the need for pre‐functionalization of the substrate. The method is operationally simple and affords straightforward access to radiolabeled N‐heteroaromatics with high molar activity suitable for biological in vivo studies and clinical application.